2022 Annual Meeting: Industry Non-CME Programs
Don't miss the latest from industry at the 2022 AAD Annual Meeting!
The Industry Non-CME (INC) Program at the 2022 AAD Annual Meeting is your chance to learn about the latest from industry. INC Programs take place after scientific sessions in the evening and are solely developed and delivered by the sponsor. They do not qualify for continuing medical education (CME) credit.
Thursday, March 24
When: Thursday, March 24 | 7:00 p.m. Program
Where: Momentum D | Omni Boston Hotel at the Seaport
Targeting New Pathways in Alopecia Areata: The Role of JAK Inhibitors
Although some may dismiss it as a mere cosmetic problem, alopecia areata (AA) affects 1% to 2% of the population and has a significant psychosocial impact on those who suffer from the disease, sometimes leading to social isolation, anxiety, and feelings of inauthenticity. Given the relatively small patient population and lack of approved agents, clinicians are not up to date on the latest clinical trial data, in their ability to assess the impact on patients and to compare/contrast new and emerging therapies with established treatment options. This initiative will address these gaps to improve diagnosis, treatment, and management of patients with AA.
When: Thursday, March 24 | 6:30 p.m. Registration | 7:00 p.m. Program
Where: Momentum A, B, C | Omni Boston Hotel at the Seaport
View more information.
Friday, March 25
When: Friday, March 25 | 6:30 p.m. Registration | 7:00 p.m. Program
Where: Momentum D | Omni Boston Hotel at the Seaport
The Impact of Immunotherapy in Patients with Advanced Non-melanoma Skin Cancer: Focusing in on Patient Identification and Treatment Optimization
Join Drs. Chrysalyn Schmults and Ann Silk as they discuss the clinical application of the novel immunotherapeutic agents for patients with non-melanoma skin cancer with personal perspectives from Dale Biggs, a patient who was treated for advanced cutaneous squamous cell carcinoma. As new options bring new hope for patients with non-melanoma skin cancer, come listen to how the experts in care implement personalized approaches in their practice to enhance patient outcomes and optimize treatment protocols.
When: Friday, March 25 | 6:30 p.m. Registration | 7:00 p.m. Program
Where: Pacific Grand Ballroom DE | Renaissance Boston Waterfront Hotel
View more information.
Bench to Clinic: Innovations in Immunodermatology and Emerging Treatment Approaches
This is an opportunity to learn about the unmet needs in the management of patients with inflammatory skin diseases; the role of current and emerging cytokine-targeting pathways in psoriasis, atopic dermatitis, and hidradenitis suppurativa; and, the emerging treatment options and management approaches that may help address unmet needs in clinical practice.
When: Friday, March 25 | 6:30 p.m. Registration | 7 p.m. Dinner | 7:30 p.m. Program
Where: Momentum A, B, C | Omni Boston Hotel at the Seaport
Saturday, March 26
Advances in Understanding Alopecia Areata and the Challenge of Special Body Areas in Psoriasis
This is an opportunity to learn about advances in understanding alopecia areata and a deep dive into psoriasis of the scalp, nails, genitals, and palmoplantar regions. Learn the latest information available on the pathogenesis, diagnosis, and assessment of alopecia areata and gain insight into the impact of psoriasis across challenging body areas.
When: Saturday, March 26 | 6:30 p.m. Registration | 7:00 p.m. Program
Where: Pacific Grand Ballroom D | Renaissance Boston Waterfront Hotel
Advancements in Atopic Dermatitis: Understanding the Role of IL-13 and Clinical Decisions in Adult Atopic Dermatitis
Extraordinary advancements have been made in our understanding of the complex pathophysiology of atopic dermatitis. The Type 2 cytokine IL-13 has been identified as having a central role in inflammation, itch, barrier dysfunction, and dysbiosis in atopic dermatitis patients. Understanding the pathogenesis can help inform treatment decisions for adult moderate to severe atopic dermatitis patients.
When: Saturday, March 26 | 6:30 p.m. Registration | 7:00 p.m. Program
Where: Momentum D | Omni Boston Hotel at the Seaport
Addressing the Burden of Prurigo Nodularis: Expert Insight on Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
This unique “Clinical Consult” live workshop from PeerView addresses questions and dilemmas faced by community providers and patients with prurigo nodularis (PN) by providing practical guidance on how to effectively integrate the latest evidence and expert recommendations into real-world clinical scenarios. This activity will provide clinicians with the necessary tools to effectively navigate the rapidly changing landscape for PN, using patient videos to convey key information regarding the burden of PN and optimal management strategies.
When: Saturday, March 26 | 6:30 p.m. Registration | 7:00 p.m. Program
Where: Momentum A, B, C | Omni Boston Hotel at the Seaport
View more information.
Sunday, March 27
Taking the Flare Out of Atopic Dermatitis: The Role of Systemic Therapies in Children
In this live symposium, Drs. Amy Paller and Peter Lio provide their guidance on the role of systemic therapies for the management of children with atopic dermatitis. A patient advocate, Amy Chrnelich, will also discuss the burden of disease and the improvements seen with systemic treatment.
Supported by: An independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals
When: Sunday, March 27 | 6:30 p.m. Registration | 7:00 p.m. Program
Where: Momentum A, B, C | Omni Boston Hotel at the Seaport
View more information.
Advances in Chronic Spontaneous Urticaria: Expert Insight on Translating Progress to Practice for Improved Symptom Control and Quality of Life
In this PeerView live “Master Class and Practicum” event, expert faculty will address current diagnostic/treatment strategies for chronic spontaneous urticaria (CSU) and the latest clinical data regarding emerging therapies, as well as the mechanisms of action, efficacy, and safety of these novel agents. They will provide practical guidance on how to effectively integrate the latest evidence and expert recommendations into real-world clinical scenarios, providing the necessary tools to effectively navigate the rapidly changing landscape for CSU.
When: Sunday, March 27 | 6:30 p.m. Registration | 7:00 p.m. Program
Where: Atlantic ABC | Renaissance Boston Waterfront Hotel
View more information.
Under the Surface: Exploring the Pathophysiology and Unmet Needs in Patients with Psoriasis
This educational symposium will explore fresh insights into the pathophysiology of psoriasis and deep dive into the unmet needs that patients have and how this relates to their evolving expectations.
When: Sunday, March 27 | 7:00 p.m. Registration | 7:30 p.m. Program
Where: Momentum D | Omni Boston Hotel at the Seaport
View more information.
